RT @synovialjoints: Dual IL-17A/F inhibition with Bimekizumab reduced MRI inflammatory change in the SIJ and spine in Ax
Tweet Content
Dual IL-17A/F inhibition with Bimekizumab reduced MRI inflammatory change in the SIJ and spine in AxSpA, and increasing proportion achieving MRI remission at Wk52, Abst#POS0246 #EULAR2023 @RheumNow https://t.co/w4VkkUklGl
Show on Archive Page
On
Display in Search Results
On
PDQ
Off